MOMENTUM 3B | Announcement

Speeches Shim

USAID AWARDS $55 MILLION TO PROTECT AGAINST VACCINE-PREVENTABLE DISEASES AND STRENGTHEN ROUTINE IMMUNIZATION PROGRAMS

A nurse vaccinates a baby at a clinic in Accra, Ghana.
A nurse vaccinates a baby at a clinic in Accra, Ghana.
Photo Credit: Kate Holt/MCSP

On July 27, 2020, the U.S. Agency for International Development (USAID) launched the latest in a series of new global health awards to accelerate reductions in maternal, newborn, and child mortality and morbidity in high-burden countries. This award, valued at up to $55 million and subject to annual appropriations, falls under the MOMENTUM suite of projects. The MOMENTUM suite aims to increase the capacity of host country institutions and local organizations to introduce, deliver, scale-up, and sustain the use of evidence-based, high-quality maternal, newborn, and child health care, voluntary family planning, and reproductive health care.

MOMENTUM 3B will focus on sustainably strengthening routine immunization programs by identifying and addressing persistent bottlenecks and barriers in the planning, delivery, demand, and uptake of immunization services. Declining and stagnating immunization rates over the last several years put mothers and children at risk of disease, and even death, in many countries.

This award will also focus on addressing the challenges posed by the disruption of immunization services due to the COVID-19 pandemic; and support countries to prepare for the future introduction and delivery of vaccines against COVID-19.

The project will be implemented by JSI Research & Training Institute, alongside six partners: PATH, CORE Group, Results for Development (R4D), The Manoff Group (TMG), Gobee Group, and Accenture Development Partnerships.

This investment comes at a pivotal moment, with the global community committing to achieving equitable access to vaccines for all by 2030 and the COVID-19 pandemic disrupting immunization services worldwide.

Vaccines remain one the world's most important tools for protecting against emerging and re-emerging infectious diseases both at home and abroad.

Last updated: March 01, 2021

Share This Page